Figure 3. Low AMH is associated with age, taking hydroxycarbamide and MCV.

Box plots of univariate analysis of AMH in the first MSH follow-up visit. Fifty six subjects had a sample available at the first visit. Box plots compare subjects ≥/< 35 years of age, with BMI ≥/< 25, by randomization to placebo or hydroxycarbamide in the MSH RCT, hydroxycarbamide use at the time of sample, and MCV ≥/< 100fL. AMH is lower in older subjects, those taking hydroxycarbamide and those with an MCV greater than 100fL.